Close Menu

NEW YORK (360DX) – Texas-based United Allergy Services filed suit against Quest Diagnostics late last month, accusing the lab giant of conspiring with other market players to eliminate lower-priced competition.

The allergy company alleges that Quest and co-conspirators have cost the company $200 million in lost profits. Specifically, the suit alleges that Quest and other players in the industry convinced insurers and potential UAS customers that doing business with UAS "caused medical, legal and other risks."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.